Evidence map›Paper›PMID 33950413›Full record

ReviewClinical & experimental metastasis2022

Secondary lymphedema from cancer therapy.

Michael Bernas, Saskia R J Thiadens, Paula Stewart, Jay Granzow

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Clinical & experimental metastasis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06750679 (MANUAL LYMPH DRAINAGE IN LOWER EXTREMITY LYMPHEDEMA MANAGEMENT), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06750679 nacompletednot on this mapstarted 2024, after this paper: background citation

Manual lymph drainage in lower extremity lymphedema management: an essential component or an optional extra ? - a single-blind, randomized non-inferiority trial

TypeinterventionalSponsorAbant Izzet Baysal UniversityRan2024 to 2026Enrolled31ConditionsLower Extremity LymphedemaArmsCompression bandage, Manual lymphatic drainage added to compression
3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Etiology and treatment of cancer-related secondary lymphedema.Clinical & experimental metastasis · 2024
    Review
  6. Supermicrosurgical lymphovenous anastomosis.Journal of the Chinese Medical Association : JCMA · 2024
    Review
  7. Review
  8. Increased infiltration of CD4BMC immunology · 2023
    Article
  9. Review
  10. Review
  11. Introduction: Novel Frontiers in Cancer Metastasis.Clinical & experimental metastasis · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael BernasTCU and UNTHSC School of Medicine, Fort Worth, TX, USA. m.bernas@tcu.edu.ORCID 0000-0002-6749-2551
Saskia R J ThiadensCalifornia Pacific Medical Center Cancer Center, CPMC, San Francisco, CA, USA.
Paula StewartParkridge Medical Center Rehabilitation, Chattanooga, TN, USA.
Jay GranzowDivision of Plastic Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This manuscript is a summary of findings focusing on various aspects of secondary lymphedema specifically as a sequelae of treatment for cancer. The topic was addressed at a session held during the 8th International Congress on Cancer Metastasis that was unique a for the inclusion of patients with lymphedema and therapists joining physicians, healthcare professionals, and researchers in an effort to give an overview of secondary lymphedema following cancer therapy as well as highlighting the unknowns in the field. Lymphedema is defined and both diagnosis and incidence of cancer-related lymphedema are explored. Further, exploration of imaging options for lymphedema and information on the genetic research for patients with cancer-related secondary lymphedema are presented. Patient education and early detection methods are then explored followed by conservative treatment. Finally, an examination of surgical treatment methods available for patients with lymphedema is covered. Overall, this manuscript presents valuable information and updates for those not familiar with incidence, diagnosis, early detection, and rehabilitation of patients with cancer-related secondary lymphedema.

Indexed as

LymphedemaNeoplasmsHumansAdvocacyDiagnosisGeneticsImagingLymphedemaTreatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.